Elucidating spray-dried dispersion dissolution mechanisms with focused beam reflectance measurement: contribution of polymer chemistry and particle properties to performance.


Journal

Pharmaceutical development and technology
ISSN: 1097-9867
Titre abrégé: Pharm Dev Technol
Pays: England
ID NLM: 9610932

Informations de publication

Date de publication:
Nov 2019
Historique:
pubmed: 15 1 2019
medline: 22 1 2020
entrez: 15 1 2019
Statut: ppublish

Résumé

Amorphous spray-dried dispersions (SDDs) are a key enabling technology for oral solid dosage formulations, used to improve dissolution behaviour and clinical exposure of poorly soluble active pharmaceutical ingredients (APIs). Appropriate assessment of amorphous dissolution mechanisms is an ongoing challenge. Here we outline the novel application using focused beam reflectance measurement (FBRM) to analyse particle populations orthogonal to USP 2 dissolution. The relative impact of polymer substitution and particle attributes on 25% BMS-708163/HPMC-AS SDD dissolution was assessed. Dissolution mechanisms for SDDs were categorized into erosion versus disintegration. Beyond an initial mixing period, FBRM particle counts diminish slowly and particles are detectable until the point where API dissolution is complete. There is correlation between FBRM particle count decay rate, representing loss of SDD particles in the dissolution media, and UV dissolution rate, measuring dissolved API. For the SDD formulation examined, the degree of succinoyl substitution for HPMC-AS, SDD particle size and surface area all had an impact on dissolution. These data indicate the SDD displayed an erosion mechanism and that FBRM is capturing a rate-limiting step. From this screening tool, the mechanistic understanding and measured impact of polymer chemistry and particle properties can inform a risk-assessment and control strategy for this compound.

Identifiants

pubmed: 30640552
doi: 10.1080/10837450.2018.1559189
doi:

Substances chimiques

BMS 708163 0
Excipients 0
Oxadiazoles 0
Sulfonamides 0
hydroxypropylmethylcellulose-lactose matrix 0
Methylcellulose 9004-67-5
Amyloid Precursor Protein Secretases EC 3.4.-
Lactose J2B2A4N98G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1055-1062

Auteurs

Clare Frances Rawlinson-Malone (CF)

Bristol-Myers Squibb, Drug Product Science and Technology , Moreton , UK.

Ana Patricia Ferreira (AP)

Bristol-Myers Squibb, Drug Product Science and Technology , Moreton , UK.

Daniel Nicholls (D)

School of Pharmacy, University of Reading, Reading , UK.

Sarah Nicholson (S)

Bristol-Myers Squibb, Drug Product Science and Technology , Moreton , UK.

Articles similaires

Humans Surgical Staplers Surgical Stapling Postoperative Complications Treatment Outcome
Humans Small Cell Lung Carcinoma RNA, Long Noncoding Sulfonamides Animals
Animals Robotics Algorithms Sperm Whale Vocalization, Animal
Inclusion Bodies Solubility Recombinant Proteins Detergents Protein Denaturation

Classifications MeSH